Cyclization of PLP 139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis

[img]
Preview
Ep37224_CyclicPLPv5copy.pdf - Accepted Version (805kB) | Preview

Lourbopoulos, A, Matsoukas, MT, Katsara, M, Deraos, G, Giannakopoulou, A, Lagoudaki, R, Grigoriadis, N, Matsoukas, J and Apostolopoulos, Vasso ORCID: 0000-0001-6788-2771 (2018) Cyclization of PLP 139-151 peptide reduces its encephalitogenic potential in experimental autoimmune encephalomyelitis. Bioorganic and Medicinal Chemistry, 26 (9). 2221 - 2228. ISSN 0968-0896

Dimensions Badge

Altmetric Badge

Item type Article
URI https://vuir.vu.edu.au/id/eprint/37224
DOI https://doi.org/10.1016/j.bmc.2017.12.024
Official URL https://www.sciencedirect.com/science/article/pii/...
Subjects Historical > FOR Classification > 1107 Immunology
Historical > FOR Classification > 1116 Medical Physiology
Historical > Faculty/School/Research Centre/Department > Centre for Chronic Disease Prevention and Management
Current > Division/Research > College of Health and Biomedicine
Keywords cPLP analog; EAE; peptides; cyclic PLP
Citations in Scopus 7 - View on Scopus
Download/View statistics View download statistics for this item

Search Google Scholar

Repository staff login